Retina Foundation of the Southwest

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Retina Foundation of the Southwest sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 5 currently recruiting 4 completed early-phase tilt top decile by trial count

Retina Foundation of the Southwest: 11 sponsored US clinical trials, 5 recruiting.

Retina Foundation of the Southwest sponsors 11 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Amblyopia, with 5 trials.

Top-decile sponsor footprint

Retina Foundation of the Southwest ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

11 total, page 1 of 1

RECRUITING NA

Improving Control of Intermittent Exotropia

NCT07272005
RECRUITING NA

Amblyopia Treatment for Children Aged 8 to 12 Years

NCT07281742
RECRUITING NA

Patch-free Occlusion Therapy

NCT05440448
RECRUITING NA

Video Treatment for Amblyopia

NCT05439200
RECRUITING NA

Binocular Amblyopia Treatment

NCT03288948
ACTIVE NOT RECRUITING NA

Improving Control of Alignment in Intermittent Exotropia

NCT04199871
ACTIVE NOT RECRUITING NA

Binocular iPad Sub-Study

NCT02365090
COMPLETED NA

Dichoptic Video Treatment for Amblyopia

NCT03825107
COMPLETED

Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)

NCT03322930
COMPLETED NA

Effect of Long-Chain Polyunsaturated Fatty Acid Supplementation on Toddler Cognition

NCT00982462
COMPLETED Phase 2

DHA and X-Linked Retinitis Pigmentosa

NCT00100230

Phase Distribution

PhaseTrial count
Phase 2 1

Therapeutic Areas

Amblyopia 5
Intermittent Exotropia 1

What is open in the Retina Foundation of the Southwest pipeline

5 recruiting of 11 indexed (45% open); 4 completed (36%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Amblyopia (5 trials), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Retina Foundation of the Southwest: open-pipeline peers nationwide

Peers matched on 11 registered trials and 45% open enrollment, not the therapeutic-area sidebar.

Retina Foundation of the Southwest sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10121416182022 0%10%20%30%40%50% Total trials Recruiting share Retina Foundation of the SouthwestAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeSouthern College of OptometryUniversity of Tennessee Graduate School of MedicineNader SanaiPraxis Precision Medicines
Retina Foundation of the Southwest sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Retina Foundation of the Southwest sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 45% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Retina Foundation of the Southwest page

11 registered trials is a research-attention snapshot, not an endorsement of Retina Foundation of the Southwest or any single study.

  • 5 of Retina Foundation of the Southwest's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Amblyopia is the condition Retina Foundation of the Southwest studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Amblyopia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Retina Foundation of the Southwest pipeline card: 11 registered trials from official public datasets.Report a data error.